Variable | Outcomes number (%) | Crude OR (95% CI) | Adjusted OR (95% CI) | p value | |
---|---|---|---|---|---|
Deceased | Alive | ||||
Age category | |||||
18–28 years | 17 (29.8) | 75 (39.1) | 1 | 1 | |
29–40 years | 23 (40.4) | 78 (40.6) | 0.77 (0.38,1.55) | 0.78 (0.38–1.60) | 0.491 |
> 40 years | 17 (29.8) | 39 (20.3) | 0.52 (0.24,1.13) | 0.54 (0.24–1.20) | 0.129 |
CPT | |||||
Not received | 11 (19.3) | 80 (41.7) | 2.98 (1.46,6.12) | 2.59 (1.22–5.59) | 0.013* |
Received | 46 (80.7) | 112 (58.3) | 1 | 1 | 1 |
Tracing methods | |||||
Phone | 16 (28.1) | 79 (41.1) | 1.79 (0.94,3.42) | 1.53 (0.78–3.02) | 0.217 |
Field work | 41 (71.9) | 113 (58.9) | 1 | 1 | 1 |
Clinical stage | |||||
I/II | 16 (28.1) | 64 (33.3) | 1 | 1 | |
III | 22 (38.6) | 85 (44.3) | 0.97 (0.45,1.99) | 1.03 (0.49–2.17) | 0.932 |
IV | 19 (33.3) | 43 (22.4) | 0.57 (0.26,1.22) | 0.69 (0.31–1.54) | 0.369 |
Follow-up time | |||||
< 12 months | 40 (70.2) | 120 (62.5) | 1 | 1 | |
> 12 months | 17 (29.8) | 72 (37.5) | 1.41 (0.75,2.67) | 1.57 (0.77–2.94) | 0.231 |